Fundraising Fox

Biotech Investors & VC Firms in Global

642 firms in this list, with a median first check of $500K. 156 of them lead rounds. Generated from verified public data and updated continuously.

Capital Cell
BarcelonaPre-Seed–Growth
Intermediate Capital Group
LondonGrowth–Late Stage$5M – $50M
16 people
Maxpro Ventures
TaipeiSeed–Late Stage$10M – $13M
7 people
Brunnur Ventures GP
ReykjavikPre-Seed–Series A$1M – $3M
9 people
MBX Capital
ClaymontPre-Seed–Series A$250K – $2.5M
5 people
MRL Ventures Fund
CambridgePre-Seed–Series B$25M
8 people
Oyster Bay Venture Capital
BerlinPre-Seed–Series B$1M – $5M
11 people
Speciale Invest
ChennaiPre-Seed–Seed$1M
11 people
AIR Capital
Buenos AiresPre-Seed–Series A
2 people
PAI Partners
ParisGrowth–Late Stage$108M – $324M
13 people
INCE Capital
ShanghaiSeed–Late Stage
9 people
NVentures
Santa ClaraPre-Seed–Series A
3E Bioventures Capital
Palo AltoSeed–Series A
5 people
Marathon Venture Capital
AthensSeed–Series B$250K – $1M
5 people
Boundary Capital
NorthamptonPre-Seed–Growth$190.5K – $635K
2 people
Starfish Ventures
MelbournePre-Seed–Growth$2M – $3.3M
2 people
Woori Technology Investment
Seoul
19 people
IDG Capital
Hong KongPre-Seed–Late Stage$3M – $200M
6 people
LifeArc Ventures
LondonSeed–Growth
12 people
MVM Life Science Partners
LondonSeed–Late Stage$20M – $100M
11 people
Ally Bridge Group
New YorkSeed–Late Stage
7 people
SABIC Ventures
SittardSeed–Late Stage$500K – $20M
10 people
3B Future Health Fund
MonacoPre-Seed–Late Stage$12M
12 people
Apex Innovative Investments Ventures
VancouverPre-Seed–Series A$250K
9 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.